Lloyd’s seems to be breathing easily, but the US insurance industry will be dreading the legal bill as its ‘blue blood’ investment bank, Goldman Sachs, squares up to the regulator over claims that an alleged conflict of interest amounted to fraud
We’re glad you’ve chosen Insurance Times as your source for industry news and hope you’ve been enjoying reading articles from our award-winning team of journalists.
Gain access to more of our exclusive, breaking stories, interviews and news analysis as it happens. Registering is quick, easy, free, and will also have the additional benefits:
Stay on top of the insurance game with our subscription! Get unlimited access to over 80,000 articles, in-depth analysis, exclusive reports by industry experts, and our Five-Star rating system to compare companies and find the best fit for your business needs - view subscription options.